Signet Therapeutics

Biotechnology

Organoid- and AI-driven cancer drug discovery

Signet Therapeutics is a clinical-stage biotech company pioneering the development of first-in-class targeted cancer therapies using organoids and AI.

Haisheng Zhang

Founder and CEO

Favorite Innovator

Accept the things I cannot change. Change the things I can.

Reinhold Niebuhr